SMMT

Summit Therapeutics Inc.

CIK 0001599298 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations

$13.16

↑ 0.73 (5.87%)

as of Aug 21, 2026

End-of-day close, not real-time intraday

Live price (Google Finance) ↗

Overall read: NeutralOverall score · based on 4/4 lenses

FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals

Key stats

Market Cap

$10.50B

P/E Ratio

-12.26

EPS

-1.44

Dividend Yield

Not covered

52W Position

Beta

1.61

Valuation multiples

Fwd P/E

3.72

PEG

0.00

P/B

16.66

P/S

Not covered

EV/Revenue

Not covered

ROE

-135.9%

Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 6%

$12.07$30.05

Latest Financials

2025-12-31 FY

Revenue

–

Net Income

-$1.08B

Total Assets

$751.18M

Free Cash Flow

-$323.59M

SMMT

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news

SMMT

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news